THE CONTENT OF MCP-1 AND MMP-9 IN BLOOD SERUM OF PATIENTS WITH CHRONIC POLYPOID RHINOSINUSITIS

The content of MCP-1 and MMP-9 inblood serum of patients with chronic polypoid rhinosinusitis was studied. It was found that this pathology led to a significant increase in MCP-1, which is a marker of fibrosis, in blood serum. The compensatory increase in MMP-9, serving as an antifibrotic factor, is...

Full description

Bibliographic Details
Main Authors: A. I. Onischenko, O. A. Nakonechna, A. S. Tkachenko, Yu. M. Kalashnik
Format: Article
Language:English
Published: V. N. Karazin Kharkiv National University 2017-06-01
Series:Journal of V. N. Karazin Kharkiv National University: Series Medicine
Online Access:http://periodicals.karazin.ua/medicine/article/view/9135/8654
Description
Summary:The content of MCP-1 and MMP-9 inblood serum of patients with chronic polypoid rhinosinusitis was studied. It was found that this pathology led to a significant increase in MCP-1, which is a marker of fibrosis, in blood serum. The compensatory increase in MMP-9, serving as an antifibrotic factor, is much weaker. Such imbalance between profibrotic MCP-1 and antifibrotic MMP-9 indicates a lack of compensatory adaptation mechanisms of fibrolysis activation and contributes to the development of fibrosis in chronic polypoid rhinosinusitis.
ISSN:2313-6693
2313-2396